Preceptis Medical, Inc.

Company Summary

Preceptis Medical is a US based, privately-held pediatric ENT device company commercializing the HummingbirdTM TTS, a surgical technology to minimize trauma during ear tube placements in children allowing the use of moderate sedation outside the operating room.

Transaction Overview

On 13 June, 2018, Preceptis Medical announced that it has closed its Series B financing led by a group of Chinese private investors with follow-on funding by Montesy Helen (HK) Limited.
In conjunction with the financing, Preceptis’ Chinese partners will be distributing the Hummingbird in mainland China and Hong Kong.

Significance of the Transaction

The Series B financing allows the Company to expand its commercial infrastructure, complete its office indication study, and develop future pipeline services and technologies.

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Private Placement

Preceptis Medical, Inc.

Has completed its $6,000,000 equity financing by a syndicate of individual investors

The undersigned acted as an advisor to Preceptis Medical